1. Home
  2. DOGZ vs TNYA Comparison

DOGZ vs TNYA Comparison

Compare DOGZ & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DOGZ

Dogness (International) Corporation

HOLD

Current Price

$1.21

Market Cap

153.5M

ML Signal

HOLD

Logo Tenaya Therapeutics Inc.

TNYA

Tenaya Therapeutics Inc.

HOLD

Current Price

$0.67

Market Cap

178.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DOGZ
TNYA
Founded
2003
2016
Country
China
United States
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
153.5M
178.5M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
DOGZ
TNYA
Price
$1.21
$0.67
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$5.33
AVG Volume (30 Days)
33.8K
2.8M
Earning Date
04-01-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
54.96
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.02
$0.36
52 Week High
$30.00
$2.35

Technical Indicators

Market Signals
Indicator
DOGZ
TNYA
Relative Strength Index (RSI) 30.85 43.98
Support Level $1.02 $0.65
Resistance Level $1.45 $0.82
Average True Range (ATR) 0.08 0.05
MACD 0.02 -0.00
Stochastic Oscillator 31.88 7.30

Price Performance

Historical Comparison
DOGZ
TNYA

About DOGZ Dogness (International) Corporation

Dogness (International) Corp designs, manufactures pet products, including leashes and smart products, and lanyards. The company designs, processes, and manufactures fashionable and high-quality leashes, collars, and harnesses to complement cats' and dogs' appearances, as well as intelligent pet products. The company also provides dyeing services to external customers, as well as pet grooming services. The dyeing service is to utilize the existing production capacity and the pet grooming service is immaterial. Geographically, it generates maximum revenue from Mainland China and also has a presence in the United States, Europe, Australia, Canada, Central, and South America, Japan, and other Asian countries and regions.

About TNYA Tenaya Therapeutics Inc.

Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.

Share on Social Networks: